Company
United StatesPublic company, NASDAQ: NEPHNephros, Inc. (NASDAQ: NEPH), South Orange, NJ – FDA Inspections
Inspection records and compliance data for Nephros, Inc. in South Orange, New Jersey. 3 FDA inspections on record (2 OAI), 1 warning letter, last inspected February 22, 2016. Publicly traded as NASDAQ: NEPH.
Company Profile
This profile covers Nephros, Inc. based in South Orange, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 2
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 1
First inspected November 13, 2013. Last inspected February 22, 2016.
Most cited issue areas
- Records of complaint investigation2 inspections
- Date of Event1 inspection
- Design changes - Lack of or Inadequate Procedures1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 22, 2016 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 967762 |
| October 24, 2014 | OAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 905362 |
| November 13, 2013 | OAI | Medical Devices & Rad Health · Compliance: Devices | 851457 |
FDA documents
Warning Letters (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Nephros, Inc.
Stock ticker
NEPH
Exchange
NASDAQ
Share price
$3.31
Market cap
$36.0M
Price as of
November 13, 2026
FEI Number
3003337893
Address
380 Lackawanna Pl, South Orange, New Jersey 07079, United States
Country
United States
ID: 748317fb-e75e-45ff-8356-313d1a1efaed